4-CHLORO-6-METHYL-1-(2,2,2-TRIFLUOROETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDINE

Catalog No. :
ACQNRD277
CAS No. :
2005389-35-3
Molecular Formula :
C8H6ClF3N4
Molecular Weight :
250.61

IUPAC Name:4-chloro-6-methyl-1-(2,2,2-trifluoroethyl)-1H-pyrazolo[3,4-d]pyrimidine

4-CHLORO-6-METHYL-1-(2,2,2-TRIFLUOROETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDINE structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$512.00Login to see priceInquiryInquiry
1g95%$1282.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-CHLORO-6-METHYL-1-(2,2,2-TRIFLUOROETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDINE
IUPAC Name4-chloro-6-methyl-1-(2,2,2-trifluoroethyl)-1H-pyrazolo[3,4-d]pyrimidine
MDL No.MFCD30829837
Molecular FormulaC8H6ClF3N4
Molecular Weight250.61
SMILESFC(F)(CN1N=CC2=C(N=C(N=C21)C)Cl)F
InChI KeyKRDISYMEALOZCJ-UHFFFAOYSA-N
Synonym4-Chloro-6-methyl-1-(2,2,2-trifluoroethyl)pyrazolo[3,4-d]pyrimidine;1H-Pyrazolo[3,4-d]pyrimidine, 4-chloro-6-methyl-1-(2,2,2-trifluoroethyl)-
CAS No.2005389-35-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACQNRD277 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQNRD277 route product structure diagram
    ACQNRD2772005389-35-3
Inquiry

2. ACQNRD277 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAPWE251 route compound structure diagram
    ACAPWE25130129-53-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQNRD277 route product structure diagram
    ACQNRD2772005389-35-3
Inquiry

Comments (0)